Literature DB >> 25892518

PML suppresses IL-6-induced STAT3 activation by interfering with STAT3 and HDAC3 interaction.

Masaya Kato1, Ryuta Muromoto1, Sumihito Togi1, Masashi Iwakami1, Yuichi Kitai1, Shigeyuki Kon1, Kenji Oritani2, Tadashi Matsuda3.   

Abstract

The promyelocytic leukemia protein PML acts as a tumor suppressor by forming transcription-regulatory complexes with a variety of repressor proteins. In the present study, we found that endogenous PML suppresses interleukin (IL)-6-induced gene expression as well as phosphorylation and transcriptional activation of STAT3 in hepatoma cells. We also found that PML-mediated suppression of IL-6-induced STAT3 activation by disrupting interactions between STAT3 and HDAC3. These results indicate that PML modulates IL-6-induced STAT3 activation and hepatoma cell growth by interacting with HDAC3.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HDAC3; Hepatoma; IL-6; PML; STAT3; Transcriptional regulation

Mesh:

Substances:

Year:  2015        PMID: 25892518     DOI: 10.1016/j.bbrc.2015.04.040

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

1.  Dual regulation of Stat1 and Stat3 by the tumor suppressor protein PML contributes to interferon α-mediated inhibition of angiogenesis.

Authors:  Kuo-Sheng Hsu; Xuan Zhao; Xiwen Cheng; Dongyin Guan; Ganapati H Mahabeleshwar; Yu Liu; Ernest Borden; Mukesh K Jain; Hung-Ying Kao
Journal:  J Biol Chem       Date:  2017-04-21       Impact factor: 5.157

Review 2.  TRIM proteins in hepatocellular carcinoma.

Authors:  Kan Lu; Yonglong Pan; Zhao Huang; Huifang Liang; Ze-Yang Ding; Bixiang Zhang
Journal:  J Biomed Sci       Date:  2022-09-13       Impact factor: 12.771

3.  ESCC ATLAS: A population wide compendium of biomarkers for Esophageal Squamous Cell Carcinoma.

Authors:  Asna Tungekar; Sumana Mandarthi; Pooja Rajendra Mandaviya; Veerendra P Gadekar; Ananthajith Tantry; Sowmya Kotian; Jyotshna Reddy; Divya Prabha; Sushma Bhat; Sweta Sahay; Roshan Mascarenhas; Raghavendra Rao Badkillaya; Manoj Kumar Nagasampige; Mohan Yelnadu; Harsh Pawar; Prashantha Hebbar; Manoj Kumar Kashyap
Journal:  Sci Rep       Date:  2018-08-24       Impact factor: 4.379

4.  Interaction of promyelocytic leukemia/p53 affects signal transducer and activator of transcription-3 activity in response to oncostatin M.

Authors:  Jiwoo Lim; Ji Ha Choi; Eun-Mi Park; Youn-Hee Choi
Journal:  Korean J Physiol Pharmacol       Date:  2020-05-01       Impact factor: 2.016

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.